Since the Doudna and Charpentier labs first realized the gene-editing capabilities of the CRISPR/Cas9 system, the field expanded outward until it could be found in every corner of biological research. Whether it’s discovering oncogenes, tracking chromosomal recombination, building gRNA libraries, or identifying protein-binding domains for drug development, the versatility of CRISPR/Cas9 continues to captivate the scientific research community. It is this very captivation that has driven the surge in customer demand for CRISPR/Cas9 consumables and services over the past four years. In order to understand the key elements driving this revolutionary field, we asked more than 1350 scientists from around the world about their experience with CRISPR/Cas9 technology suppliers, including their brand perceptions, overall satisfaction, buying preferences, and preferred products. Our latest report—The 2016 Market for CRISPR/Cas9 Products & Services—includes their responses coupled with a wealth of valuable market information and derived metrics straight from the most important source: scientific customers.
Our 2016 report incorporates data from our 2015 survey and assembles it into accessible graphs and metrics for quick comparison. Based on these historical data, we are able to construct financial models to predict market growth. Furthermore, we can contrast these models with market growth as predicted by the scientists themselves. For example, over the next 12 months scientists expect lab budgets for CRISPR/Cas9 technology to increase by over 35%, dwarfing predicted growth in cell-based assays by nearly three times. With expansion of this magnitude, companies with well established supply chains for cell-based assays will need to leverage their strengths to engender the same level of consumer preference in their CRISPR/Cas9 consumables. In order to do so, they will need to gather the pertinent market information, especially with regards to the perception of their brand. As we demonstrate in our report, current use and loyalty are not mutually exclusive.
When it comes to maintaining a healthy brand, scientists are your greatest advocates. Their satisfaction with your company can quickly manifest as a promoting comment to a colleague or department, perhaps to one of the 16% who are in search of a new supplier. Conversely, a scathing review from a dissatisfied customer puts your brand in jeopardy of garnering the wrong sort of reputation. The reputation you create for your company becomes the single most important driver of new business. In a fast-growing, dynamic market like CRISPR, smaller, innovative companies have an opportunity to demonstrate their expertise and win share before the industry’s giants establish themselves.
Relative to 2015, leading causes of customer satisfaction remain unchanged. Cost, product quality, and technical support are the strongest drivers of switching behavior. However, regional differences in the value placed on each metric are striking. While European labs consider poor technical support to be an excusable flaw, 61% of scientists in Asia consider it to be a justifiable reason for switching suppliers. Regional trends should influence strategic marketing, with successful campaigns being regionally attuned and highly adaptable to consumer interest. Our 2016 report consolidates consumer data into an easily navigated format with, giving you the choice to optimize your research by continent, market segment, and over 20 leading companies.